Primemd Inc.
PRMD · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $15 | $7 | $1 |
| - Cash | $3 | $2 | $0 | $2 |
| + Debt | $7 | $7 | $0 | $8 |
| Enterprise Value | $9 | $21 | $7 | $7 |
| Revenue | $2 | $3 | $5 | $1 |
| % Growth | -52.8% | -24.7% | 512.7% | – |
| Gross Profit | $2 | $3 | $5 | $1 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $3 | -$0 | $0 | $1 |
| % Margin | 207.1% | -8.2% | 4.9% | 91.5% |
| Net Income | $3 | -$0 | $0 | $1 |
| % Margin | 159.9% | -10.8% | 4.8% | 88.5% |
| EPS Diluted | 0.14 | -0.02 | 0.012 | 0.036 |
| % Growth | 796.5% | -268.9% | -66.7% | – |
| Operating Cash Flow | $5 | -$1 | -$1 | $0 |
| Capital Expenditures | -$1 | $0 | $0 | -$0 |
| Free Cash Flow | $4 | -$1 | -$1 | $0 |